DOI: https://doi.org/10.24959/sphhcj.20.181

The substantiation of the technology of the bigel hydrophilic faction for the complex therapy of mastopathy in the aspect of methodological approaches to drug creation

S. S. Zuikina, L. I. Vyshnevska

Abstract


Aim. To develop methodological approaches to creation of a bigel and substantiate the technology of the hydrogel fraction as one of the components of the bigel for the complex therapy of mastopathy and prevention of breast cancer.

Materials and methods. The study objects were a hydrophilic gelling agent – hydroxyethyl cellulose (HЕС) and active pharmaceutical ingredients (AFI) – indomethacin, a liquid extract of hop cones (1 : 2), potassium iodide and magnesium sulfate. The methods of analysis of electronic and paper sources of information on advantages, technology, and methods of analysis of bigels were used. The methods of pharmacotechnological studies were applied when developing the technology and studying the critical parameters of the hydrophilic fraction of the bigel.

Results. Over the last several decades, different types of gels have been widely studied as potential carriers for drug delivery. In recent years, many scientists proposed the development of formulations by mixing a hydrogel and an oleogel. These compositions are regarded as bigels. Since hydrogels are polar, while oleogels are non-polar, the bigel can be considered as emulsions with the internal and external immobilized phases. The advantages of the bigel system include the possibility of introducing both hydrophilic and lipophilic substances, providing the local action or transdermal drug delivery, improving the consumption properties of drugs. In addition, in the scientific papers of Almeida at el. it has been shown that bigel-based preparations have a moisturizing and cooling effect. Considering the number of advantages of the bigel systems over mono- and emulsion gels, the possibility of reproduction of their technology and research methods we can conclude that the development of this dosage form for the treatment of local and systemic diseases is promising. Because of the lack of soft medicines in the form of bigels at the domestic pharmaceutical market the aim of the work was to develop the composition and technology of a bigel for the complex therapy of mastopathy. The general methodological approach to pharmaceutical drug development (LP) is standardized in the ICH Q8 guidance, with which the guidance of ST-N MOH 42-3.0:2011 “Medicines. Pharmaceutical development (ICH Q8)” is harmonized. Taking into account the above we have proposed the algorithm for the methodological approach to the development of the composition of the hydrogel fraction as a component of the bigel for the complex therapy of mastopathy.

Conclusions. The modern results of studying bigels in the world pharmaceutical practice (advantages, principles of development and analysis) have been analyzed and systematized. The methodological approach to the bigel development has been proposed. The technological parameters of the hydrogel fraction production and the rational way of introducing AFI to the composition of the hydrophilic gel base have been determined.


Keywords


methodology; technology; bigel; mastopathy

References


Paul, S. R., Qureshi, D., Yogalakshmi, Y., Nayak, S. K., Singh, V. K., Syed, I., Sarkar, P., Pal, K. (2018). Development of bigels based on stearic acid-rice bran oil oleogels and tamarind gum hydrogels for controlled delivery applications. J Surfact Deterg., 21 (1), 17-29. doi: 10.1002/jsde.12022.

Shakeel, A., Farooq, U., Iqbal, T., Yasin, S., Lupi, F. R., Gabriele, D. (2019). Key characteristics and modeling of bigels systems: A review. Materials Science & Engineering C, 97, 932–953. doi: 10.1016/j.msec.2018.12.075.

Patel, A. R. Manko, B., Bin Sintang, M. D., Lesafferb, A., Dewettincka, K. (2015). Fumed silica-based organogels and ‘aquatic-organic’ bigels. RSC Adv., 5 (13), 9703-9708. doi: 10.1039/C4RA15437A.

Zuikina, S., Vyshnevska, L. (2019). Research on the development of the basis of combined gel for mastopathy treatment. Proceedings from Science and Practice 2019 : 10th International Pharmaceutical Conference (November 15th, 2019) (p. 107). Kaunas, Lithuania.

DP “Ukrainskyi naukovyi farmakopeinyi tsentr yakosti likarskykh zasobiv”. (2014). Derzhavna farmakopeia Ukrainy. (1st ed.). (Vol. 2). Kharkiv, 724.

Mazurkeviciute, A., Ramanauskiene, K., Ivaskiene, K. M., Grigonis, A., Briedis, V. (2018). Topical antifungal bigels: Formulation, characterization and evaluation. Acta Pharm., 68 (2), 223–233. doi: 10.2478/acph-2018-0014.

Andonova, V., Peneva, P., Apostolova, E., Dimchev, T., Peychev, Zh., Kassarova, M. (2017). Carbopol hydrogel / sorbitan monostearate-almond oil based organogel biphasic formulations: Preparation and characterization of the bigels. Tropical Journal of Pharmaceutical Research, 16 (7), 1455–1463. doi: 10.4314/tjpr.v16i7.1.

Martins, A. J., Silvaa, P., Maciela, F., Pastranab, L. M., Cunhac, R. L., Cerqueirab, M. A., Vicente, A. A. (2019). Hybrid gels: Influence of oleogel / hydrogel ratio on rheological and textural properties. Food Research International, 116, 1298–1305. doi: 10.1016/j.foodres.2018.10.019.

Immink, J. N., Maris, J. J. E., Crassous, J. J., Stenhammar, J., Schurtenberger, P. (2019). Reversible formation of thermoresponsive binary particle gels with tunable structural and mechanical properties. ACS Nano, 13 (3), 3292–3300. doi: 10.1021/acsnano.8b09139.

Gönüllü, Ü., Şaki, D. (2017). Formulation and characterization of norethisterone transdermal patch as an alternative route to oral administration. Tropical Journal of Pharmaceutical Research, 16 (12), 2785–2792. doi: 10.4314/tjpr.v16i12.1.

Potapov, V. A. (2016). Multitargetnyi podkhod k lecheniiu fibrozno-kistoznoi mastopatii i profilaktike raka molochnoi zhelezy. Zdorove zhenshchiny, 1 (107),18–29. doi: 10.15574/HW.2016.107.18.

Liapunov, N. A., Bezuglaia, E. P., Zinchenko, I. A., Liapunov, A. N., Stolper, Yu. M. (2014). Miagkie lekarstvennye sredstva: farmatcevticheskaia razrabotka i transfer tekhnologii. Farmatcevticheskaia otrasl, 5 (46), 22–31.

Liapunov, N. A., Bezuglaia, E. P. (2013). Metodologiia farmatcevticheskoi razrabotki lekarstvennykh preparatov v Ukraine. Farmatciia, 7, 44–49.


GOST Style Citations


1. Development of bigels based on stearic acid–rice bran oil oleogels and tamarind gum hydrogels for controlled delivery applications / Paul S. R. et al. J Surfact Deterg. 2018. Vol 21, Issue 1. P. 17-29. doi: 10.1002/jsde.12022.

 

2. Key characteristics and modelling of bigels systems: A review / A. Shakeel et al. Materials Science & Engineering C. 2019. Vol. 97. P. 932–953. doi: 10.1016/j.msec.2018.12.075.

 

3. Fumed silica-based organogels and ‘aqueous-organic’ bigels / A. R. Patel et al. RSC Advances. 2015. Vol. 5, Issue 13. P. 9703–9708. doi: 10.1039/C4RA15437A.

 

4. Zuikina S., Vyshnevska L. Research on the development of the basis of combined gel for mastopathy treatment. Science and Practice 2019 : Proceedings of the 10th International Pharmaceutical Conference,  November 15th, 2019. Kaunas, Lithuania, 2019. P. 107.

 

5. Державна фармакопея України / ДП «Український науковий фармакопейний центр якості лікарських засобів». 1-е вид. Харків, 2014. Т. 2. 724 с.

 

6. Topical antifungal bigels: Formulation, characterization and evaluation / A. Mazurkeviciute et al. Acta Pharm. 2018. Vol. 68 (2). P. 223–233. doi: 10.2478/acph-2018-0014.

 

7. Carbopol hydrogel/sorbitan monostearate-almond oil based organogel biphasic formulations: Preparation and characterization of the bigels / V. Andonova et al. Tropical Journal of Pharmaceutical Research. 2017. Vol. 16 (7). P. 1455–1463. doi: 10.4314/tjpr.v16i7.1.

 

8. Hybrid gels: Influence of oleogel/hydrogel ratio on rheological and textural properties / A. J. Martinsaet al. Food Research International. 2019. Vol. 116. P. 1298–1305. doi: 10.1016/j.foodres.2018.10.019.

 

9. Reversible formation of thermoresponsive binary particle gels with tunable structural and mechanical properties / J. N. Immink et al. ACS Nano. 2019. Vol. 13 (3). P. 3292−3300. doi: 10.1021/acsnano.8b09139.

 

10. Gönüllü Ü., Şaki D. Formulation and characterization of norethisterone transdermal patch as an alternative route to oral administration. Tropical Journal of Pharmaceutical Research. 2017. Vol. 16 (12). P. 2785–2792. doi: 10.4314/tjpr.v16i12.1.

 

11. Потапов В. А. Мультитаргетный подход к лечению фиброзно-кистозной мастопатии и профилактике рака молочной железы. Здоровье женщины. 2016. № 1 (107). С .18–29. doi: 10.15574/HW.2016.107.18.

 

12. Мягкие лекарственные средства: фармацевтическая разработка и трансфер технологии / Н. А. Ляпунов и др. Фармацевтическая отрасль. 2014. № 5 (46). С. 22–31.

 

13. Ляпунов Н. А., Безуглая Е. П. Методология фармацевтической разработки лекарственных препаратов в Украине. Фармация. 2013. № 7. С. 44–49.





Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Abbreviated key title: Soc. pharm. health care

ISSN 2518-1564 (Online), ISSN 2413-6085 (Print)